20260409_MEDC_Laporan Informasi dan Fakta Material_32069377_lamp1.pdf

Regulation S berdasarkan U.S Securities Act
(“Surat Utang Baru”). Surat Utang Baru akan
dianggap sebagai “Surat Utang Tambahan”
berdasarkan Indenture yang mengatur Surat
Utang Senior jatuh tempo 2030 dengan jumlah
pokok agregat sebesar US$400.000.000 dan
tingkat bunga sebesar 8,625Yoyang diterbitkan
pada tanggal 19 Mei 2025. /

Medco Cypress Tree Pte. Ltd., an indirectly
wholly owned subsidiary of the Company
through Medco Strait Services Pte. Ltd., plans
to issue US$200,000,000 aggregate principal
amount of its 8.62596 Senior Notes due 2030
at an issue price of 103,07296, outside the
territory of the Republic of Indonesia pursuant
to Regulation S under the U.S. Securities Act
(the “New Notes”) The New Notes will
constitute “Additional Notes” under the
Indenture — governing the outstanding
US$400,000,000 aggregate principal amount
of 862546 Senior Notes due 2030 issued on 19
May 2025.

Uraian Informasi atau Fakta
Material / Description of Material
Information or Facts

Ijaminan perusahaan yang diterbitkan oleh

Surat Utang Baru tersebut dijamin dengan

Perseroan dan beberapa anak perusahaan
Perseroan, dimana hasil bersih Surat Utang
Baru tersebut akan digunakan untuk memberi
pinjaman kepada Perseroan dan/atau satu
atau lebih perusahaan anak terbatas, antara
lain untuk melakukan penawaran pembelian
(tender), pembiayaan kembali (refinancing),
atau pelunasan atas utang yang telah ada
(termasuk surat utang yang diterbitkan pada
tahun 2026 dan/atau 2028 melalui penawaran
pembelian, pelunasan lebih awal (redemption),
atau pembelian lainnya), termasuk setiap
premi, bunga yang telah terakru, serta biaya
atau pengeluaran yang timbul sehubungan
dengan hal-hal tersebut di atas.

Rencana penerbitan Surat Utang Baru ini
bukan merupakan suatu penawaran umum
sebagaimana dimaksud dalam Undang-
Undang No. 8 Tahun 1995 tentang Pasar
Modal sebagaimana terakhir diubah dengan
Undang-Undang No. 4 Tahun 2023 tentang
Pengembangan dan Penguatan Sektor
Keuangan sebagaimana diubah dengan
Undang-Undang No. 1 tahun 2026 tentang
Penyesuaian Pidana dan bukan merupakan
suatu penerbitan surat utang tanpa melalui
penawaran umum sebagaimana dimaksud
dalam Peraturan OJK No. 30/POJK.04/2019
tentang Penerbitan Efek Bersifat Utang |

2 214

dan/atau Sukuk Yang Dilakukan Tanpa Melalui
Penawaran Umum.

Lebih lanjut, rencana penerbitan Surat Utang
Baru serta jaminan perusahaan yang diberikan
oleh Perseroan dan beberapa anak-anak
perusahaan Perseroan sehubungan dengan
Surat Utang Baru ini bukan merupakan
transaksi material sebagaimana diatur dalam
Peraturan OJK No. 17/POJK.04/2020 tentang
Transaksi Material dan Perubahan Kegiatan
Usaha.

The New Notes will be guaranteed by
corporate guarantees issued by the Company
and several of its subsidiaries, and the net
proceeds from the New Notes will be used to
provide loans to the Company and/or one or
more restricted subsidiaries, among other
things, to conduct tender offers, refinancing, or
repayment of existing indebtedness (including
| notes issued in 2026 and/or 2028 through

tender offers, redemption, or other purchases),
| including any premiums, accrued interest, and

fees or expenses incurred in connection with
| the foregoing.

The issuance of the New Notes does not
constitute a public Offering as referred to in Law
No. 8 of 1995 on Capital Markets, as lastiy
amended by Law No. 4 of 2023 on the
Development and Strengthening of the
Financial Sector as amended by Law No. 1 of
2026 on the Adjustment of Criminal Penalties,
and does not constitute an issuance of debt
securities without a public offering as referred
to in OJK Regulation No. 30/POJK.04/2019 on
the Issuance of Debt Securities and/or Sukuk
Conducted Without a Public Offering.

Furthermore, the proposed issuance of the
New Notes, as well as the corporate
guarantees provided by the Company and
several of its subsidiaries, in connection with
the New Notes does not constitute a material
transaction as stipulated under OJK
Regulation No. 17/POJK.04/2020 on Material
Transactions and Changes in Business
Activities.

Dampak kejadian, informasi atau

fakta material tersebut terhadap
kegiatan — operasional, hukum,
kondisi keuangan, atau

kelangsungan usaha Emiten atau
Perusahaan Publik / Impact of such
material information or fact to the

Dalam hal Surat Utang Baru tersebut berhasil
diterbitkan, maka hal tersebut akan
menyebabkan bertambahnya kewajiban
keuangan Perseroan secara konsolidasi,
namun tidak berdampak secara negatif
terhadap kegiatan operasional, hukum / In the
event that such New Notes is successtfully

314

Company's operational, law, | issues, such issuance will result in an increase
financial condition or business in the Company's consolidated financial
Oobligations: however, it does not have any
adverse impact on the Company's operational
activities or legal condition.

5. | Keterangan lain-lain / Other | -
information

Demikian informasi ini kami sampaikan. Atas perhatian dan kerjasamanya, kami mengucapkan
terima kasih / Thank you for your attention and cooperation.

Hormat kami / Regards,
PT Medco Energi Internasional Tbk

S Pa AE
s Ge

Nama / Name : Siendy K. Wisandana
Jabatan / Title : Corporate Secretary

Tembusan / Copied to:

1. Kepala Biro PKP Sektor Riil Otoritas Jasa Keuangan / Head of Corporate Financial
Assessment Bureau of the Financial Services Authority

2. Direktur Pencatatan PT Bursa Efek Indonesia / Director of Listing of PT Bursa Efek

Indonesia

Page a14

Not for distribution, directly or indirectly, in or into the United States orto any U.S. persons (as defined below).

MEDCOENERGI

Medco Cypress Tree Pte. Ltd.
(incorporated with limited liability under the laws of Singapore)

PRICING OF US$200,000,000 8.625 SENIOR NOTES DUE 2030 TO BE CONSOLIDATED AND
FORM A SINGLE CLASS WITH THE EXISTING US$400,000,000 8.625/o SENIOR NOTES DUE
2030 OF MEDCO CYPRESS TREE PTE. LTD. ISSUED ON 19 MAY 2025

Medco Cypress Tree Pte. Ltd. (the “Issuer”) wishes to announce that it has priced US$200,000,000
aggregate principal amount of its 8.625” Senior Notes due 2030 (the “Notes”) to be consolidated and
form a single class with its existing US$400,000,000 aggregate principal amount of the 8.625”4 Senior
Notes due 2030 issued on 19 May 2025.

The Notes will be issued at an issue price of 103.072Y4 of their principal amount, plus accrued interest
from (and including) 19 November 2025 to (but excluding) the issue date of the Notes. The Notes are
expected to be issued on or about 15 April 2026.

Approval in-principle has been received from the Singapore Exchange Securities Trading Limited (the
“SGX-ST”) for the listing and guotation of the Notes on the Official List of the SGX-ST. The SGX-ST
assumes no responsibility for the correctness of any of the statements made or opinions expressed or
reports contained herein. Admission to the Official List of the SGX-ST and guotation of the Notes on
the SGX-ST is notto be taken as an indication of the merits of the Issuer, its subsidiaries, its associated
companies or the Notes. The Notes are expected to be listed on the SGX-ST on or about 16 April 2026.

Medco Cypress Tree Pte. Ltd.
(UEN/Company Registration No. 202512442H)

9 April 2026

This announcement is not for distribution in the United States or to any U.S. persons (as defined under the Securities Act). The
Notes referred to herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended
(the “Securities Act”) or with any securities regulatory authority of any state or other jurisdiction in the United States, and may
not be offered or sold, directly or indirectly, into the United States unless the Notes referred to herein are so registered or an
exemption from the registration reguirements is available. There will be no public offering of the Notes referred to herein in the
United States. Accordingly, the Notes described herein will be offered and sold only outside the United States to non-U.S. persons
in reliance on Regulation S under the Securities Act. Nothing in this communication shall constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the Notes in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or gualification under the securities laws of any such jurisdiction. This announcement does
not constitute a public offering in Indonesia under Law Number 8 of 1995 regarding Capital Market as amended by Law No. 4of
2023 on Development and Strengthening of Financial Sectors as amended by Law No. 1 of 2026 on the Adjustment of Criminal
Penaities and its implementing regulations (the “Indonesian Capital Market Law'). The issuance of the Notes does not constitute
(iya public offering in Indonesia under the Indonesian Capital Market Law and (ii) a private placement of debt securities under
OJK Regulation No. 30/POJK.04/2019 on the Issuance of Debt-Linked Securities and/or Sukuk issued by way of Private
Placement and its implementing regulations. The Notes may not be offered or sold in Indonesia or to Indonesian nationals,
wherever they are domiciled, or to Indonesian residents, in a manner that constitutes a public offering or private placement of
debt securities under the laws and regulations of Indonesia.